Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of anticancer agents. Its structure allows for selective modification to enhance binding affinity to specific enzyme targets. Commonly employed in medicinal chemistry for constructing pyrrolopyrimidine-based scaffolds, which show activity against tyrosine kinases involved in tumor growth and proliferation. Also utilized in research settings to design new pharmaceuticals with improved metabolic stability and bioavailability.